Back to Search Start Over

Assessment of Time to CAR-T Cell Therapy and Patients’ Outcomes in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Based on Insurance Status (Public Versus Private) and Distance Traveled to Treatment Center

Authors :
Elnair, Radowan
Thiel, Grace
Schmit-Pokorny, Kim
Swanson, Deborah
Jourdan, Dawn
Franco, Theresa
Shostrom, Valerie K
Armitage, James O
Bierman, Philip J.
Bociek, R. Gregory
Kallam, Avyakta
Vose, Julie M.
Lunning, Matthew
Source :
Transplantation and Cellular Therapy; March 2021, Vol. 27 Issue: 3, Number 3 Supplement 1 pS302-S303, 2p
Publication Year :
2021

Details

Language :
English
ISSN :
26666375 and 26666367
Volume :
27
Issue :
3, Number 3 Supplement 1
Database :
Supplemental Index
Journal :
Transplantation and Cellular Therapy
Publication Type :
Periodical
Accession number :
ejs55218829
Full Text :
https://doi.org/10.1016/S2666-6367(21)00384-5